CD19-Targeted immunotherapies for Treatment of Pediatric t(8;21) Leukemia

被引：0
|
作者：
Barneh, F. [1 ]
Meulendijks, T. [1 ]
Wijnen, N. [1 ]
Koedijk, J. [1 ]
Ashtiani, M. [1 ]
Krippner-Heidenreich, A. [1 ]
Dunnebach, E. [1 ,2 ]
Nierkens, S. [1 ,2 ]
Kaspers, G. [1 ]
Heidenreich, O. [1 ,3 ]
机构：
[1] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[2] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Translat Immunol, Utrecht, Netherlands
[3] Newcastle Univ, Wolfson Childhood Canc Res Ctr, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England
来源：
KLINISCHE PADIATRIE | 2023年 / 235卷 / 03期
关键词：
D O I：
10.1055/s-0043-1768497
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
0001
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [1] A review of CD19-targeted immunotherapies for relapsed or refractory acute lymphoblastic leukemia
    DasGupta, Ryan K.
    Marini, Bernard L.
    Rudoni, Joslyn
    Perissinotti, Anthony J.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (06) : 453 - 467
  • [2] Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia
    Barneh, Farnaz
    Koedijk, Joost B.
    Wijnen, Noa E.
    Meulendijks, Tom
    Ashtiani, Minoo
    Dunnebach, Ester
    Dautzenberg, Noel
    Cornel, Annelisa M.
    Krippner-Heidenreich, Anja
    Klein, Kim
    Zwaan, C. Michel
    Kuball, Juergen
    Nierkens, Stefan
    Cloos, Jacqueline
    Kaspers, Gertjan J. L.
    Heidenreich, Olaf
    HAEMATOLOGICA, 2024, 109 (12) : 4131 - 4136
  • [3] Novel Chimeric Antigen Receptor T Cells for the Treatment of CD19-Negative Relapses Occurring after CD19-Targeted Immunotherapies
    Ruella, Marco
    Barrett, David
    Kenderian, Saad S.
    Shestova, Olga
    Hofmann, Ted J.
    Scholler, John
    Lacey, Simon F.
    Melenhorst, Jan J.
    Nazimuddin, Farzana
    Kalos, Michael
    Porter, David L.
    June, Carl H.
    Grupp, Stephan A.
    Gill, Saar I.
    BLOOD, 2014, 124 (21)
  • [4] CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma
    Gambella, Massimiliano
    Carlomagno, Simona
    Raiola, Anna Maria
    Giannoni, Livia
    Ghiggi, Chiara
    Setti, Chiara
    Giordano, Chiara
    Luchetti, Silvia
    Serio, Alberto
    Bo, Alessandra
    Falco, Michela
    Della Chiesa, Mariella
    Angelucci, Emanuele
    Sivori, Simona
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] CD19-targeted immunotherapies for treatment of patients with non-Hodgkin B-cell lymphomas
    Watkins, Marcus P.
    Bartlett, Nancy L.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (07) : 601 - 611
  • [6] Humanized CD19-targeted chimeric antigen receptor T (CAR-T) cells for relapsed/refractory pediatric acute lymphoblastic leukemia
    Wang, Shiyuan
    Wang, Xue
    Ye, Chunying
    Cheng, Hai
    Shi, Ming
    Chen, Wei
    Qi, Kunming
    Wang, Gang
    Wu, Qingyun
    Zeng, Lingyu
    Li, Zhenyu
    Jing, Guangjun
    Zheng, Junnian
    Xu, Kailin
    Cao, Jiang
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : E162 - E165
  • [7] Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies
    Ghobadi, Armin
    Landmann, Jack H.
    Carter, Alun
    Cooper, Matthew L.
    Selli, Mehmet Emrah
    Chang, Jufang
    Baker, Matthew
    Miller, Christopher A.
    Ferraro, Francesca
    Chen, David Y.
    Smith, Amanda M.
    LaValle, Taylor A.
    Duncavage, Eric J.
    Chou, Justin
    Tam, Victor
    Benoun, Joseph M.
    Nater, Jenny
    Scholler, Nathalie
    Milletti, Francesca
    Vezan, Remus
    Bot, Adrian
    Rossi, John M.
    Singh, Nathan
    BLOOD ADVANCES, 2022, 6 (20) : 5634 - 5640
  • [8] CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
    Maude, Shannon L.
    Teachey, David T.
    Porter, David L.
    Grupp, Stephan A.
    BLOOD, 2015, 125 (26) : 4017 - 4023
  • [9] Treatment of two pediatric patients with refractory systemic lupus erythematosus using CD19-targeted CAR T-cells
    He, Xue
    Hu, Bin
    Zhang, Yingzi
    Liu, Fei
    Li, Qiuyu
    Zheng, Chen
    Shen, Junjie
    Yang, Zhi
    Wang, Jingjing
    Ma, Daqing
    Qian, Cheng
    Lu, Meiping
    Mao, Jianhua
    AUTOIMMUNITY REVIEWS, 2025, 24 (01)
  • [10] Understanding Outcomes of CD19-Targeted CAR T Cell Immunotherapy
    Turtle, Cameron J.
    BLOOD, 2017, 130
12345